In this retrospective analysis, we attempted to investigate whether machine learning techniques may improve the FET-PET-based discrimination between PSP and true progression (TP) in patients with newly diagnosed isocitrate dehydrogenase (IDH) wildtype glioblastoma. This evidence concerns the gene IDH1 and glioblastoma.